B. Riley reiterated their buy rating on shares of Augmedix (OTCMKTS:AUGX – Get Rating) in a report released on Thursday morning, PriceTargets.com reports.
Augmedix Stock Performance
OTCMKTS:AUGX opened at $1.56 on Thursday. The company has a current ratio of 2.07, a quick ratio of 2.07 and a debt-to-equity ratio of 2.04. The firm has a 50-day moving average price of $1.29 and a two-hundred day moving average price of $1.52. Augmedix has a twelve month low of $1.01 and a twelve month high of $3.55. The company has a market capitalization of $58.38 million, a P/E ratio of -2.33 and a beta of -0.65.
Get
Augmedix alerts:
Hedge Funds Weigh In On Augmedix
Several hedge funds have recently added to or reduced their stakes in AUGX. Russell Investments Group Ltd. purchased a new position in Augmedix during the 2nd quarter valued at about $592,000. Samjo Capital LLC purchased a new stake in shares of Augmedix during the first quarter worth about $779,000. Millrace Asset Group Inc. grew its holdings in shares of Augmedix by 16.9% during the second quarter. Millrace Asset Group Inc. now owns 909,492 shares of the company's stock worth $1,637,000 after buying an additional 131,708 shares in the last quarter. Blair William & Co. IL grew its holdings in shares of Augmedix by 577.5% during the first quarter. Blair William & Co. IL now owns 124,825 shares of the company's stock worth $367,000 after buying an additional 106,400 shares in the last quarter. Finally, TownSquare Capital LLC grew its holdings in shares of Augmedix by 31.6% during the second quarter. TownSquare Capital LLC now owns 274,791 shares of the company's stock worth $495,000 after buying an additional 65,981 shares in the last quarter. 73.93% of the stock is currently owned by hedge funds and other institutional investors.
About Augmedix
(Get Rating)
Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals.
Recommended Stories
- Get a free copy of the StockNews.com research report on Augmedix (AUGX)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Is Kintara Therapeutics A Hidden Gem?
- Should You Warm up to Generac Stock for the Winter?
Receive News & Ratings for Augmedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Augmedix and related companies with MarketBeat.com's FREE daily email newsletter.
B.莱利重申了他们对以下股票的买入评级Augmedix(OTCMKTS：AUGX-GET Rating)在周四上午发布的一份报告中，PriceTargets.com报道。
Augmedix股票表现
OTCMKTS：AUGX周四开盘报1.56美元。该公司的流动比率为2.07，速动比率为2.07，债务权益比率为2.04。该公司的50日移动均线价格为1.29美元，200日移动均线价格为1.52美元。8月期胶的12个月低点为1.01美元，12个月高位为3.55美元。该公司市值为5838万美元，市盈率为-2.33，贝塔系数为-0.65。
到达
Augmedix警报：
对冲基金看涨8月Medix
几家对冲基金最近增持或减持了AUGX的股份。罗素投资集团有限公司在第二季度购买了Augmedix的一个新头寸，价值约592,000美元。Samjo Capital LLC在第一季度购买了Augmedix的新股份，价值约77.9万美元。今年第二季度，Millrace Asset Group Inc.持有的Augmedix股票增加了16.9%。Millrace Asset Group Inc.现在持有该公司909,492股股票，价值1,637,000美元，上个季度又购买了131,708股。第一季度，Blair William&Co.IL持有的Augmedix股票增加了577.5%。Blair William&Co.IL现在持有124,825股该公司股票，价值367,000美元，上个季度又购买了106,400股。最后，TownSquare Capital LLC在第二季度持有的Augmedix股票增加了31.6%。Townsquare Capital LLC现在持有274,791股该公司股票，价值495,000美元，上个季度又购买了65,981股。73.93%的股票目前由对冲基金和其他机构投资者持有。
关于Augmedix
(获取评级)
Augmedix，Inc.在美国提供远程医疗文档解决方案和实时临床支持服务。它的平台提供Augmedix Live和Augmedix Notes解决方案，这些解决方案提供访问前文档，如以前记录/患者历史的预制图表和数字化；访问期间文档，包括医疗记录、护理差距提醒、肝细胞癌提醒和访问后摘要；以及访问后文档，包括编码、订单和推荐。
推荐故事
- 免费获取StockNews.com 8月Medix上的研究报告(AUGX)
- MarketBeat：回顾一周12/26-12/30
- 科技狗：是时候咬一口这些股票了
- 这笔收购会让微软成为熊市买入者吗？
- 金塔拉治疗公司是一颗隐藏的宝石吗？
- 你应该热身到Generac股票过冬吗？
接收8月媒体日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Augmedix和相关公司的最新新闻和分析师评级的每日简要摘要。
